Avisi Technologies, Inc

PHILADELPHIA, PA · Medtech · Private

Ultrathin corrugated microstructure implant for glaucoma that reduces intraocular pressure while minimizing scarring and patient discomfort

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
PHILADELPHIA, PA
Latest Form D
$5.3M, Nov 2022
Total capital
$6.6M
Federal grants
$1.2M
2 awards · 2019–2020
Rank in peer group#386 of 477
Private capital raised
$5.3M
1 Form D · last Nov 2022
47 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
19 pending · first 2025
Rank in peer group#99 of 477

Capital timeline

2019202020212022FEDERAL ↑EQUITY ↓Cumulative $6.6M$225K$1M1st Form D$5.3M
2019202020212022FEDERAL ↑EQUITY ↓Cumulative $6.6M$225K$1M1st Form D$5.3M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$5.3M
  • Federal grantNSF · Phase II · SBIR Phase II: Nanotechnology-Enabled Implant for Controlling Intraocular Pressure$1M
  • Federal grantNSF · Phase I · SBIR Phase I: Nanotechnology-Enabled Implant for Controlling Intraocular Pressure$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

41months

from Avisi Technologies, Inc’s first federal award to its first private round.

First federal award · Jul 2019
NSF · $225K
First Form D · Nov 2022
$5.3M · 1st Form D
Awards before first raise
2 awards

An association in public records, not a cause or a prediction.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#99 · top 21%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Rui Jing JiangResearcherExecutive Officer, DirectorLinked by 2 patents
  • Brandon KaoDirectorNamed in SEC Form D filings
  • Catherine MohrDirectorNamed in SEC Form D filings
  • Gary PrudenDirectorNamed in SEC Form D filings
  • Paul NorrisDirectorNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 22
Show all 22 patent records
  • Insertion Tool For An Eye Disease Treatment DeviceMay 12, 2026 · US 12,622,811Granted
  • Method And Device For Treating Eye DiseaseMar 12, 2026 · Application 19391743Pending
  • Method And Device For Treating Eye DiseaseNov 18, 2025 · US 12,472,096Granted
  • Method And Device For Treating Eye DiseaseSep 11, 2025 · Application 19212334Pending
  • Markings Or Geometric Guides To Facilitate Placement And Trajectory Of Surgical Sutures For Thin-film Ocular Implants In Open Or Minimally Invasive Surgical SitesJun 5, 2025 · Application 18969792Pending
  • Thin-film Ocular Implant Having A Control Structure For Regulating Aqueous FlowJun 5, 2025 · Application 18970063Pending
  • Method And Device For Treating Eye DiseaseMay 20, 2025 · US 12,303,429Granted
  • Thin-film Ocular Implant And Delivery Tool In Open Or Minimally Invasive Surgical SitesMay 1, 2025 · Application 18928567Pending
  • Vacuum-based Delivery Tool To Facilitate Placement Of Thin-film Ocular Implant In Open Or Minimally Invasive Surgical SitesDec 12, 2024 · Application 18737451Pending
  • Tunable Device For Treating Eye DiseaseJun 13, 2024 · Application 18553085Pending
  • Tunable Device For Treating Eye DiseaseApplication PCTUS2022023064Pending
  • Insertion Tool For An Eye Disease Treatment DeviceApplication 63174883Pending
  • Tunable Device For Treating Eye DiseaseApplication 63169587Pending
  • Markings Or Geometric Guides To Facilitate Placement And Trajectory Of Surgical Sutures For Thin-film Ocular Implants In Open Or Minimally Invasive Surgical SitesApplication PCTUS2024058608Pending
  • Thin-film Ocular Implant Having A Control Structure For Regulating Aqueous FlowApplication PCTUS2024058640Pending
  • Thin-film Ocular Implant And Delivery Tool In Open Or Minimally Invasive Surgical SitesApplication PCTUS2024053182Pending
  • Vacuum-based Delivery Tool To Facilitate Placement Of Thin-film Ocular Implant In Open Or Minimally Invasive Surgical SitesApplication PCTUS2024033029Pending
  • Markings Or Geometric Guides To Facilitate Placement And Trajectory Of Surgical Sutures For Thin-film Ocular Implants In Open Or Minimally Invasive Surgical SitesApplication 63606321Pending
  • Thin-film Ocular Implant Having A Control Structure For Regulating Aqueous FlowApplication 63606472Pending
  • Thin-film Ocular Implant And Delivery Tool In Open Or Minimally Invasive Surgical SitesApplication 63594284Pending
  • Vacuum-based Delivery Tool To Facilitate Placement Of Thin-film Ocular Implant In Open Or Minimally Invasive Surgical SitesApplication 63507278Pending
  • Insertion Tool For An Eye Disease Treatment DeviceApplication PCTUS2022024789Pending
  • Atantares CorpSimilar federal contract value in Medtech · null in contracts
  • NEUROBIONICS INCSimilar federal contract value in Medtech · null in contracts
  • GALAXY THERAPEUTICS, LLCSimilar federal contract value in Medtech · null in contracts
  • CAIRA SURGICAL CORPSimilar federal contract value in Medtech · null in contracts
  • J3 BIOSCIENCE, INC.Similar federal contract value in Medtech · null in contracts
  • ATRILITY MEDICAL LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .